Secţiunea 3 - Conduită - Ghid din 2019 clinic privind lehuzia patologică

M.Of. 738 bis

În vigoare

Versiune de la: 10 Septembrie 2019

SECŢIUNEA 3:Conduită

1.WHO World Health Organization recommendations for prevention and treatment of maternal peripartum infections, 2015, WHO Library Cataloguing-in-Publication Data ISBN 978 92 4 154936 3

2.Managing puerperal sepsis. WHO World Health Organization 2008. Education material for teachers of midwifery: midwifery education modules. - 2nded. ISBN 978 92 4 154666 9

3.Marwah S, Topden SR, Sharma M, Mohindra R, Mittal P. Severe Puerperal Sepsis-A Simmering Menace. J Clin Diagn Res. 2017 May; 11(5):QC04-QC08.

4.Williams OBSTETRICS, 24th Edition, Editors: Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Casey BM, Sheffield JS, 2014 by McGraw-Hill Education, ISBN: 978-0-07-179894-5

5.Maternal Collapse in Pregnancy and the Puerperium, Royal College of Obstetricians & Gynaecologists, Green-top Guideline No. 56, January 2011

6.Bacterial Sepsis following Pregnancy, Royal College of Obstetricians & Gynaecologists, Green-top Guideline No. 64b, April 2012

7.Deutscher M, Lewis M, Zell ER, Taylor TH Jr, Van Beneden C, Schrag S; Active Bacterial Core Surveillance Team. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011 Jul 15; 53(2):114-23.

8.Mason KL, Aronoff DM. Postpartum group a Streptococcus sepsis and maternal immunology. Am J Reprod Immunol. 2012 Feb; 67(2):91-100.

9.Zuarez-Easton S, Zafran N, Garmi G, Salim R. Postcesarean wound infection: prevalence, impact, prevention, and management challenges. Int J Womens Health. 2017 Feb 17; 9:81-88.

10.Kramer HM, Schutte JM, Zwart JJ, Schuitemaker NW, Steegers EA, van Roosmalen J. Maternal mortality and severe morbidity from sepsis in the Netherlands. Acta Obstet Gynecol Scand. 2009; 88(6):647-53.

11.Tanaka H, Katsuragi S, Hasegawa J, Tanaka K, Osato K, Nakata M, Murakoshi T, Sekizawa A, Kanayama N, Ishiwata I, Ikeda T. The most common causative bacteria in maternal sepsis-related deaths in Japan were group A Streptococcus: A nationwide survey. J Infect Chemother. 2019 Jan; 25(1):41-44.

12.Knowles SJ, O'Sullivan NP, Meenan AM, Hanniffy R, Robson M. Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study. BJOG. 2015 Apr; 122(5):663-71.

13.Stock L, Basham E, Gossett DR, Lewicky-Gaupp C. Factors associated with wound complications in women with obstetric anal sphincter injuries (OASIS). Am J Obstet Gynecol. 2013 Apr; 208(4):327.e1-6.

14.American College of Obstetricians and Gynecologists: Use of prophylactic antibiotics in labor and delivery. Practice Bulletin No. 199, June 2018

15.Chelmow D, Ruehli MS, Huang E. Prophylactic use of antibiotics for non-laboring patients undergoing cesarean delivery with intact membranes: A meta-analysis Am J Obstet Gynecol 184 (4):656 -661, 2001

16.Andrews WW., Hauth JC., Cliver SP., et al: Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post cesarean delivery endometritis. Obstet Gynecol 101:1183, 2003

17.Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD007482.

18.Jyothirmayi CA, Halder A, Yadav B, Samuel ST, Kuruvilla A, Jose R. A randomized controlled double blind trial comparing the effects of the prophylactic antibiotic, Cefazolin, administered at caesarean delivery at two different timings (before skin incision and after cord clamping) on both the mother and newborn. BMC Pregnancy Childbirth. 2017 Oct 3; 17(1):340.

19.Assawapalanggool S, Kasatpibal N, Sirichotiyakul S, Arora R, Suntornlimsiri W, Apisarnthanarak A. The efficacy of ampicillin compared with ceftriaxone on preventing cesarean surgical site infections: an observational prospective cohort study. Antimicrob Resist Infect Control. 2018 Jan 22; 7:13.

20.Hopkis L., Smaill F.: Antibiotic prophylaxis regimens and drugs for cesarean section Cochrane Library, Chichester, Wiley Issue 1, 2003

21.Scott JR.: Cesarean Delivery, Danforth’s Obstetrics and Gynecology, 8th edition, Lippincot Williams and Wilkins, 1999, 457 - 470

22.Gyte GML, Dou L, Vazquez JC Different classes of antibiotics given to women routinely for preventing infection at caesarean section (Review). Cochrane Library, Cochrane Database of Systematic Reviews 2014, Issue 11. Art. No.: CD008726. Published by John Wiley & Sons, Ltd.

23.Valent AM, DeArmond C, Houston JM, Reddy S, Masters HR, Gold A, Boldt M, DeFranco E, Evans AT, Warshak CR. Effect of Post-Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site InfectionAmong Obese Women: A Randomized Clinical Trial. JAMA. 2017 Sep 19; 318(11):1026-1034.

24.Enkin MW., Wilkinson C.: Single verus two layer suturing forclosing the uterine incision at cesarean section. Cochrane Library, Chichester, Wiley Issue 1, 2002

25.Hauth JC., Owen J., Davis RO.: Transverse uterine incision closure: one versus two layers. Am J Obstet Gynecol, 167:1108, 1992

26.AlKhalek SAA, ElMekkawi SF, El-Kotb AM, Okily AS. Swabbing of Subcutaneous Tissues with Betadine for Prevention of Surgical Site Infection after Caesarian Section. The Egyptian Journal of Hospital Medicine. 72.9 (July 9, 2018): p5183+

27.Hauth JC., Gilstrap LC. III, Ward SC., Hankins GDV.: Early repair of an external sphincter ani muscle and rectal mucosal dehiscence. Obstet Gynecol 67:806, 1986

28.Hankins GDV., Hauth JC., Gilstrap LC., Hammond TL., Yeomans ER., Snyder RR.: Early repair of episiotomy dehiscence. Obstet Gynecol 75:48, 1990

29.Ramin SM., Ramus R., Little B., Gilstrap LC.: Early repair of episiotomy dehiscence associated with infection. Am J Obstet Gynecol 167:1104, 1992

30.Gallup DG., Meguiar RV.: Coping with necrotizing fasciitis. Contemp Ob/Gyn 49:38, 2004

31.Urschel JD.: Necrotizing soft tissue infections. Postgrad Med J 75:645, 1999

32.Zimbelman J., Palmer A., Todd J.: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infections. Pediatr Infect Dis J 18:1096, 1999

33.Caruntu AF.: Infecţiile bacteriene necrozante extensive ale ţesuturilor moi, Medicina modernă I/6 1994, 335:336

34.Luca V: Infecţia puerperală: Tratat de obstetrică (sub redacţia prof. dr. Ioan Munteanu); Editura Academiei Române; 2000; 686:734

35.Mackeen AD, Packard RE, Ota E, Speer L Antibiotic regimens for postpartum endometritis (Review) Cochrane Library, Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No.: CD001067. Published by John Wiley & Sons, Ltd.

36.Livingston JC, Llata E, Rinehart E, Leidwanger C, Mabie B, Haddad B, Sibai B. Gentamicin and clindamycin therapy in postpartum endometritis: the efficacy of daily dosing versus dosing every 8 hours. Am J Obstet Gynecol. 2003 Jan; 188(1):149-52.

37.French LM., Smaill FM.:Antibiotic regimens for endometritis after delivery The Cochrane Database of Systematic Reviews 2004, Issue 4

38.Liu C., Abate B., Reyes M., Gonik B.: Single daily dosing of gentamicin: Pharmacokinetic comparison of two dosing methodologies for postpartum endometritis. Infect Dis Obstet Gynecol 7:133, 1999

39.Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118(Suppl. 1):1-203.

40.Sam S., Corbridge TC., Mokhlesi B.: Cortisol levels and mortality in sepsis. Clin Endoccrinol (Oxf) 60:29, 2004

41.Bernard GR., Wheeler AP., Russell JA., Schein R., Summer WR., Steinberg KP., Fulkerson WJ., Wright PE., Christman BW., Dupont WD., Higgins SB., Swindell BB.: The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 336:912, 1997

42.Cronin L., Cook DJ., Carlet J., et al: Corticosteroid treatment for sepsis: a critical appraisal and meta-anallysis of the literature. Crt Care Med 23:1430, 1995

43.Mediano P, Fernandez L, Rodriguez JM, Marin M. Case-control study of risk factors for infectious mastitis in Spanish breastfeeding women. BMC Pregnancy Childbirth. 2014 Jun 6; 14:195.

44.Amir LH ABM clinical protocol #4: Mastitis, revised March 2014. Academy of Breastfeeding Medicine Protocol Committee. Breastfeed Med. 2014 Jun; 9(5):239-43.

45.Amir LH, Garland SM, Lumley J. A case-control study of mastitis: Nasal carriage of Staphylococcus aureus. BMC Fam Pract 2006; 7:57

46.Collignon PJ, Grayson ML, Johnson PDR. Methicillin resistant Staphylococcus aureus in hospitals: Time for a culture change. Med J Aust 2007; 187:4-5.

47.Nyebil JR., Spence MR., Parmley TH.: Sporadic (nonepidemic) puerperal mastitis J Reprod Med 20:97, 1978

48.Mastitis. Causes and Management, Department of Child and Adolescent, Health and Development, WHO World Health Organization, 2000, WHO/FCH/CAH/00.13

49.Sachs HC; Committee on Drugs. The transfer of drugs and therapeutics into human breast milk: An update on selected topics. Pediatrics 2013; 132:e796-e809.

50.Kvist LJ, Larsson BW, Hall-Lord ML, et al. The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment. Int Breastfeed J 2008; 3:6.

51.Pricop F, Crauciuc E: Infecţiile sânului: Tratat de obstetrică (sub redacţia prof. dr. Ioan Munteanu); Editura Academiei Române; 2000; 767:782

52.Delgado S, Arroyo R, Jimenez E, Marin ML, del Campo R, Fernandez L, Rodriguez JM. Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: potential virulence traits and resistance to antibiotics. BMC Microbiol. 2009 May 7; 9:82.

53.Jahanfar S, Ng CJ, Teng CL, Antibiotics for mastitis. Cochrane Database Syst Rev. 2013 Issue 2. Art. No.: CD005458.

54.Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic. Therapeutic Guidelines Ltd., Melbourne, 2010.

55.Lawrence RA, Lawrence RM. Breastfeeding: A Guide for the Medical Profession, 7th edition. Mosby, St. Louis, 2011.

56.Branch-Elliman W, Golen TH, Gold HS, et al. Risk factors for Staphylococcus aureus postpartum breast abscess. Clin Infect Dis 2012; 54:71-77.

57.Chen CY, Anderson BO, Lo SS, et al. Methicillin-resistant Staphylococcus aureus infections may not impede the success of ultrasound-guided drainage of puerperal breast abscesses. J Am Coll Surg 2010; 210:148-154.

58.Dabbas N, Chand M, Pallett A, et al. Have the organisms that cause breast abscess changed with time?-Implications for appropriate antibiotic usage in primary and secondary care. Breast J 2010; 16:412-415.

59.Perez A, Orta L, Padilla E, etal. CA-MRSA puerperal mastitis and breast abscess: A potential problem emerging in Europe with many unanswered questions. J Matern Fetal Neonatal Med 2013; 26:949-951.

60.Berens P, Swaim L, Peterson B. Incidence of methicillinresistant Staphylococcus aureus in postpartum breast abscesses. Breastfeed Med 2010; 5:113-115.

61.Siddall J. Postpartum infection guideline(GL893) 2015, Royal Berkshire, NHS Foundation Trust.

62.Ulitzsch D, Nyman MKG, Carlson RA. Breast abscess in lactating women: US-guided treatment. Radiology 2004; 232:904-909.

63.Christensen AF, Al-Suliman N, Nielson KR, et al. Ultrasound guided drainage of breast abscesses: Results in 151 patients. Br J Radiol 2005; 78:186-188.

64.Carter C Mastitis & Abscess guideline (GL999) 2018, Royal Berkshire, NHS Foundation Trust.

65.Karstrup S., Solvin J., Nolsoe CP., Nilsson P., Khattar S., Loren I., Nilsson A., Court-Payen M.: Acute puerperal breast abscesses. US-guided drainage. Radiology 188:807, 1993

66.O’Hara RJ., Dexter SPL., Fox JN.: Conservative management of infective mastitis and breast abcesses after ultrasonographic assessment. Br J Surg 83:1413, 1996

67.Schwarz RJ., Shrestha R.: Needle aspiration of breast abcesses. Am J Surg 182:117, 2001

68.Eryilmaz R, Sahin M, Hakan Tekelioglu M, Daldal E. Management of lactational breast abscesses. Breast. 2005 Oct; 14(5):375-9

69.Irusen H, Rohwer AC, Steyn DW, Young T. Treatments for breast abscesses in breastfeeding women. Cochrane Database Syst Rev. 2015 Aug 17; (8):CD010490

70.Kim WJ, Lee E, Kim KR, Namkoong K, Park ES, Rha DW. Progress of PTSD symptoms following birth: a prospective study in mothers of high-riskinfants. J Perinatol. 2015 Aug; 35(8):575-9.

71.Anderson CA, Connolly JP. Predicting posttraumatic stress and depression symptoms among adolescents in the extended postpartum period. Heliyon. 2018 Nov 27; 4(11):e00965.

72.Farrington FP., Ward K.: Normal Labor, Delivery and Puerperium-Danforth’s Obstetrics and Gynecology, 8th edition, Lippincot Williams and Wilkins, 1999, 91:109

73.Tiu C.: Bolile neurologice şi sarcina - Afecţiunile medicale asociate sarcinii, Ediţia a II-a sub redacţia Radu Vlădăreanu, Editura Infomedica, 2003, 349:374

74.Akladios CY, Sananes N, Gaudineau A, Boudier E, Langer B. Secondary postpartum hemorrhage. J Gynecol Obstet Biol Reprod (Paris). 2014 Dec; 43(10):1161-9.

75.Babarinsa IA, Hayman RG, Draycott TJ. Secondary post-partum haemorrhage: challenges in evidence-based causes and management. Eur J Obstet Gynecol Reprod Biol. 2011 Dec; 159(2):255-60.

76.Belfort MA, Clark SL, Saade GR, Kleja K, Dildy GA 3rd, Van Veen TR, Akhigbe E, Frye DR, Meyers JA, Kofford S. Hospital readmission after delivery: evidence for an increased incidence of nonurogenital infection in the immediate postpartum period. Am J Obstet Gynecol. 2010 Jan; 202(1):35.e1-7.

77.King PA, Duthie SJ, Dong ZG, Ma HK. Secondary postpartum haemorrhage. Aust N Z J Obstet Gynaecol. 1989 Nov; 29(4):394-8

78.Yeniel AO, Ergenoglu AM, Akdemir A, Eminov E, Akercan F, Karadadaş N. Massive secondary postpartum hemorrhage with uterine artery pseudoaneurysm after cesarean section. Case Rep Obstet Gynecol. 2013; 2013:285846.

79.Paraskevaides E, Stuart B, Gardeil F.Secondary postpartum haemorrhage from nondehisced lower caesarean section scar: a case for hysteroscopy. Aust N Z J Obstet Gynaecol. 1993 Nov; 33(4):427.

80.Pollio F, Staibano S, De Falco M, Buonocore U, De Rosa G, Di Lieto A. Severe secondary postpartum hemorrhage 3 weeks after cesarean section: alternative etiologies of uterine scar non-union. J Obstet Gynaecol Res. 2007 Jun; 33(3):360-2.

81.Adekanmi OA, Purmessur S, Edwards G, Barrington JW. Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage. BJOG. 2001 May; 108(5):541-2.

82.Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception. Int J Gynaecol Obstet. 2014 Oct; 127(1):86-9.

83.Rein DT, Schmidt T, Hess AP, Volkmer A, Schondorf T, Breidenbach M. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011 Nov-Dec; 18(6):774-8.

84.Hamerlynck TW, Blikkendaal MD, Schoot BC, Hanstede MM, Jansen FW. An alternative approach for removal of placental remnants: hysteroscopic morcellation. J Minim Invasive Gynecol. 2013 Nov-Dec; 20(6):796-802.

85.Yaju Y, Kataoka Y, Eto H, Horiuchi S, Mori R Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period (Review) Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD009328.

86.Zubor P, Kajo K, Dokus K, Krivus S, Straka L, Bodova KB, Danko J. Recurrent secondary postpartum hemorrhages due to placental site vessel subinvolution and local uterine tissue coagulopathy. BMC Pregnancy Childbirth. 2014 Feb 21; 14:80.

87.Colmorn LB, Krebs L, Langhoff-Roos J; NOSS study group. Potentially Avoidable Peripartum Hysterectomies in Denmark: A Population Based Clinical Audit. PLoS One. 2016 Aug 25; 11(8):e0161302.

88.Zwart JJ, Dijk PD, van Roosmalen J (2010) Peripartum hysterectomy and arterial embolization for major obstetric hemorrhage: a 2-year nationwide cohort study in the Netherlands. Am J Obstet Gynecol 202: 150 e151-157.

89.Nelson WL, O'Brien JM (2007) The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol 196: e9-10.

90.Yoong W, Ridout A, Memtsa M, Stavroulis A, Aref-Adib M, Ramsay-Marcelle Z, et al. (2012) Application of uterine compression suture in association with intrauterine balloon tamponade ('uterine sandwich') for postpartum hemorrhage. Acta Obstet Gynecol Scand 91: 147-151.

91.Brennan DJ, Schulze B, Chetty N, Crandon A, Petersen SG, Gardener G, et al. (2015) Surgical management of abnormally invasive placenta: a retrospective cohort study demonstrating the benefits of a standardized operative approach. Acta Obstet Gynecol Scand 94: 1380-1386.

92.Girault A, Deneux-Tharaux C, Sentilhes L, Maillard F, Goffinet F. Undiagnosed abnormal postpartum blood loss: Incidence and risk factors. PLoS One. 2018 Jan 10; 13(1):e0190845.

93.Mathur M, Ng QJ, Tagore S. Use of Bakri balloon tamponade (BBT) for conservative management of postpartum haemorrhage: a tertiary referral centre case series. J Obstet Gynaecol. 2018 Jan; 38(1):66-70.

94.Lo A, St Marie P, Yadav P, Belisle E, Markenson G. The impact of Bakri balloon tamponade on the rate of postpartum hysterectomy for uterine atony. J Matern Fetal Neonatal Med. 2017 May; 30(10):1163-1166.

95.Lee SM, Shin JH, Shim JJ, Yoon KW, Cho YJ, Kim JW, Ko HK. Postpartum haemorrhage due to genital tract injury after vaginal delivery: safety and efficacy of transcatheter arterial embolisation. Eur Radiol. 2018 Nov; 28(11):4800-4809.

96.Allan J. Jacobs "Causes and treatment of postpartum hemorrhage", 2006 UpToDate, pag. 1-13

97.Ajayi OA, Sant M, Ikhena S, Bako A. Uterine rupture complicating sequential curettage and Bakri balloon tamponade to control secondary PPH. BMJ Case Rep. 2013 Feb 6; 2013. pii: bcr2012007709.

98.Leparco S, Viot A, Benachi A, Deffieux X. Migration of Bakri balloon through an unsuspected uterine perforation during the treatment of secondary postpartum hemorrhage. Am J Obstet Gynecol. 2013 Jun; 208(6):e6-7.

99.Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am J Obstet Gynecol. 2012; 206(481):e1-7.

100.ACOG Practice Bulletin Number 186: Long-active reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017; 130(5):e251-e269. doi:10.1097/AOG.0000000000002400

101.Long-acting reversible contraception: implants and interuterine devices. ACOG Practice Bulletin No. 121, 2015.

102.Immediate postpartum long-acting reversible contraception. ACOG committee opinion, No 671, August 2016.

103.Long acting reversible contraception. Clinical Guideline. NICE 2005. nice.org. uk/guidance/cg30

104.Trends in contraceptive use worldwide, 2015. United Nations Department of economic and social affairs, population division. Access 3.16.17. http://www.un.org/en/development/desa/population/publications/pdf/family/trendsContraceptiveUse2015Report.pdf

105.Singh S, Das V, Agarwal A, et al. A dedicated postpartum intrauterine device inserter: Pilot experience and proof of concept. Glob Health Sci Pract. 2016; 4:132-140.

106.Kapp N, Curtis K. Intrauterine device insertion during the postpartum period: A systematic review. Contraception. 2009; 80:327-336.

107.Lopez LM, Bernholc A, Hubacher D, Stuart G, Haam VV. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database Syst Rev. 2015; (6):CD003036.

108.World Health Organization. WHO recommendations: optimizing health worker roles to improve access to key maternal and new born health interventions through task shifting. http://apps.who.int/iris/bitstream/handle/10665/77764/9789241504843_eng.pdf; jsessionid=1214FFA447057B3EBE1DE6B943DA9C4A?sequence=1

109.Laerdal [website]. Mama-U Postpartum Uterus Trainer [Internet]. https://laerdalglobalhealth.com/products/mama-u/

110.Cwiak, Carrie and Sarah Cordes. "Postpartum intrauterine device placement: a patient-friendly option." Contraception and reproductive medicine (2018).